[BusinessCann] ‘Big Pharma’ And ‘Black Market’ Fears In Wake Of Europe’s ‘Narcotic’ CBD Call
Any decisions concerning CBD in Europe would have little impact on the UK market, and could even be a golden opportunity for our domestic CBD industry, which is estimated to be worth £1bn by 2025.
[New Food] The Potential Impact of Classifying CBD as a Narcotic
The European Commission is reviewing whether CBD should be classified as a narcotic. Dr Parveen Bhatarah, Head of Regulatory and Compliance Unit at The Association of the Cannabinoid Industry, explains the impact this could have on both the European and UK markets.
[Food Navigator] Love Hemp: ‘We’ve positioned ourselves as a global brand’
The CBD industry has just been dealt a potentially dangerous blow, however, with the news that the European Commission is considering classifying it as a narcotic instead of a Novel Food. While a decision won’t be made before September, it could mean that hundreds of CBD and hemp products would be unable to legally retail on the European market.
[BusinessCann] Europe’s CBD U-Turn Set To Cause Widespread Harm To Businesses And Consumers
Confirmation that the European Union is looking to treat CBD as a narcotic drug have rocked the industry.
BusinessCann reported earlier this month that moves were underway to change the status of cannabidiol (CBD) in the European Union from a food to a drug.
[Food Navigator] UK cannabinoid industry spots opportunity as EC considers reclassifying CBD a narcotic
The UK could be set to emerge as a global leader in the research and development of CBD as a food ingredient after the news that the European Commission has postponed the Novel Food applications of non-synthetic CBD products as it decides whether to class non-synthetic CBD as a narcotic.
[Nutra Ingredients] CBD Novel Foods deadline fast approaching as firms embrace regulatory challenges
With UK FSA (Food Standards Agency) setting 31 March as the deadline for firms to have validated novel foods application for its #CBD products, how are firms responding to this challenge in the current climate?’
The ACI Partners with The ReLeaf CBD Podcast
The ACI is pleased to announce a partnership with The CBD Podcast by ReLeaf. The partnership commences with an interview with members of The ACI’s Regulatory and Compliance Unit, which is headed up by Dr Parveen Bhatarah. The team, which includes several new hires, ensures that our members are fully compliant with laws relating to cannabinoids.
[The Grocer] CBD will be removed from shelves next year, are you prepared?
The UK is the only market in the world where a clear regulatory framework exists for commercial adoption of CBD giving retailers the opportunity to participate in this huge market. However, they must ensure that their procurement process is able to identify the products that are fully safe and legal.
[Natural Products Global] ACI Launches CBD Safety Study Consortium as Novel Food Deadline Looms
UK trade body the Association for the Cannabinoid Industry (The ACI) will lead a new CBD safety study consortium to generate data to assess the safety of CBD and evaluate dosage impacts.
[CBD Intel] Researchers on safety and toxicity confident of hitting UK deadlines
An industry association study of the safety and toxicity of cannabinoids is expected to be completed in time to meet submission deadlines to keep CBD-containing food, beverage and supplement products on the UK market.
